| Literature DB >> 25487314 |
Monia Savi1,2, Stefano Rossi3,4, Leonardo Bocchi5, Laura Gennaccaro6, Francesca Cacciani7, Alessio Perotti8, Davide Amidani9, Rossella Alinovi10,11, Matteo Goldoni12,13, Irene Aliatis14, Pier Paolo Lottici15, Danilo Bersani16, Marco Campanini17, Silvana Pinelli18,19, Marta Petyx20, Caterina Frati21, Andrea Gervasi22, Konrad Urbanek23, Federico Quaini24, Annamaria Buschini25, Donatella Stilli26, Claudio Rivetti27, Emilio Macchi28,29, Antonio Mutti30,31, Michele Miragoli32,33, Massimiliano Zaniboni34,35.
Abstract
BACKGROUND: In light of recent developments in nanotechnologies, interest is growing to better comprehend the interaction of nanoparticles with body tissues, in particular within the cardiovascular system. Attention has recently focused on the link between environmental pollution and cardiovascular diseases. Nanoparticles <50 nm in size are known to pass the alveolar-pulmonary barrier, enter into bloodstream and induce inflammation, but the direct pathogenic mechanisms still need to be evaluated. We thus focused our attention on titanium dioxide (TiO₂) nanoparticles, the most diffuse nanomaterial in polluted environments and one generally considered inert for the human body.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25487314 PMCID: PMC4349471 DOI: 10.1186/s12989-014-0063-3
Source DB: PubMed Journal: Part Fibre Toxicol ISSN: 1743-8977 Impact factor: 9.400
Figure 1Atomic Force Microscopy analysis of titanium dioxide nanoparticles (TiO -NPs) deposited on poly-ornithine-treated mica. A. Image of deposed TiO2-NPs. B. Height profile along the white line shown in A. C. Height distribution of TiO2-NPs. D. Images of TiO2-NP aggregates (scale bars =100 nm).
Biophysical properties on TiO NPs in different solutions
|
|
|
|
|
|
|---|---|---|---|---|
| Z-Potential (mV) | −31.74 ± 1.02 | −18.36 ± 2.30 | −24.60 ± 1.61 | −13.05 ± 2.13 |
| HydrodynamicDiameter (nm) | 154 ± 3.00 | 498 ± 0.55 | 538 ± 0.37 | 449 ± 0.85 |
Figure 2Representative traces of sarcomere shortening recorded in CTRL (black) and NP (red) cardiomyocytes field-stimulated at 0.5 (A), 1 (B) and 2 (C) Hz. Graphs of resting sarcomere length (D), sarcomere fractional shortening (FS) (E), maximal rate of shortening (−dl/dtmax) (F), and maximal rate of re-lengthening (+dl/dtmax) (G). H. Pie charts of the percentages of cardiomyocytes exhibiting spontaneous contractions (SCs, stippled areas) in CTRL (white) and NPC (red) cells after 60 s of conditional training at 0.5 Hz. I. Graph of number of SCs/cardiomyocyte in the 60 s measurement period. *, p <0.01 vs. CTRL.
Figure 3Variability in resting membrane potential in cardiomyocytes exposed to TiO NPs. A. Traces representative of the three types of Vr behavior found over a 60 s recording period subsequent to conditioning training at 5 Hz for 40 beats. B. Frequency distribution of Vr for the three ΔVr types.
Figure 4TiO NPs-induced changes in cellular electrophysiology. A. Representative action potential (AP) waveforms recorded from control (CTRL, black line) and TiO2-NP (NPC, red line) cardiomyocytes at the physiological driving rate of rat heart (5 Hz). B–E. Graphs of action potential duration (APD) measured at −20 mV (APD20) and −60 mV (APD60), beat-to-beat variability of APD60 (CVAPD60), AP upstroke (UPS) and membrane capacitance (Cm). In all graphs, CTRL is given by white columns, and NPC by the red columns (n = 37 NPC and n = 49 CTRL). *, p < 0.05 vs. CTRL. F. APs simulated with the Pandit model, without (black trace, CTRL) and with (red trace, NPC) a simulated 1.5 nS constant potassium leakage.
Figure 5Instillation of TiO -NPs and recordings of cardiac electrical performance. A. Time-scale (hours) of the experimental protocol. B. Representative EGs recorded from an 8×8 epicardial electrode array. Each waveform of the grid represents the time-course of extracellular potential at the corresponding position. The scheme on the right hand side explains the EG parameters, as measured from their root mean square (RMS)-derived signals. Magenta thin trace represents the first time derivative, whose minimum value is taken as a marker of the end of the QT interval C. Representative activation time maps (isochrones, ms) from Vehicle (left) and NPR (right), showing differences in longitudinal (red arrows) and transverse (blue arrows) propagation.
In-vivo electrophysiological parameters
|
|
| |
|---|---|---|
| P wave (ms) | 33.0 ± 0.22 | 28.9 ± 0.21** |
| PQ segment (ms) | 24.2 ± 0.18 | 21.3 ± 0.21** |
| QRS complex (ms) | 16.0 ± 0.09 | 15.2 ± 0.09** |
| QT interval (ms) | 40.0 ± 0.28 | 31.1 ± 0.54** |
| RR interval (ms) | 237.6 ± 0.90 | 231.3 ± 2.47 |
| Rheobase (μA) | 21.4 ± 1.68 | 20.6 ± 2.73 |
| Chronaxie (ms) | 0.75 ± 0.04 | 0.64 ± 0.04* |
| CVI (m/s) | 0.63 ± 0.004 | 0.70 ± 0.004 |
| CVt (m/s) | 0.33 ± 0.002 | 0.32 ± 0.002 |
| Anisotropy ratio | 1.96 ± 0.01 | 2.33 ± 0.02** |
* p < 0.05 vs Vehicle **p < 0.005 vs Vehicle.
Figure 6Susceptibility to arrhythmias in Vehicle and NP rats. A. Ventricular ectopic couplet (top) and ventricular fibrillation (bottom) recorded during evaluation of the effective refractory period (ERP). Scale bar =500 ms. B. Evaluation of ERP in Vehicle and NPR. **, p < 0.005. C. Percentage of inducible arrhythmc events.
Figure 7Presence of titanium dioxide (TiO ) nanoparticles (NPs) in the rat ventricular myocardium after tracheal instillation: TEM analysis. A. Right Ventricle. Electron-dense NPs in two longitudinally oriented cardiomyocytes and in the wall of a vascular structure. B. Left Ventricle. NPs accumulating at the edge of longitudinally oriented cardiomyocytes, as well as in the sarcolemma. NPs are also present in the interstitial space, in endothelial cells and within the capillary lumen (L). C. Left ventricle. The lumen of a capillary neighboring a cardiomyocyte containing TiO2 NPs, which also appear to be connected to and engulfed by endothelial cells. GJ marks a gap junction location. Blue rectangles include areas shown at higher magnification in the lower panels (A1, B1 and C1). Scale Bars: A and B =5 μm; A1 and B1 = 2 μm; C =1 μm; C1 = 200 nm. Bottom. Ultrathin sections of lung samples from NP-exposed treated rats. D. The bronchial epithelium is apparent by the presence of ciliated cells (*). Electron-dense NPs are best seen in cytoplasm at high magnification (D1). Clusters of NPs were found within the lung parenchyma (E) and in macrophages (F). N, nucleus. G,H. The typical shape of titanium NPs is apparent at higher magnification. Scale Bars: D =5 μm; D1 = 2 μm; E =2 μm; F =1 μm; G =200 nm; H =100 nm.
Figure 8TiO NPs-induced toxicological effects. A. DNA damage detected in single isolated cardiomyocytes by Comet assay (pH >13) in CTRL (white columns) and NPC (red columns) after 1 h and 5 h of exposure. DNA damage is expressed as tail intensity (TI%; *p < 0.05). B. Percent increase of ROS in single isolated cardiomyocytes, NPC (red column) after 1 h. C. Evaluation of TBARS in trachea, lungs and heart tissue after tracheal instillation of saline solution (Vehicle) or saline solution containing TiO2-NPs (2 mg/Kg, NPR). *, p < 0.05 vs. Vehicle.